PHARMACEUTICAL COMPOSITION CONTAINING A PROSTAGLANDIN ANALOG WHICH IS A2THROMBOXANE A2 RECEPTOR ANTAGONIST

• 1. 血栓烷A2受体拮抗剂和COX－2抑制剂的药物组合 [P] . 中国专利： CN1665538A . 2005-09-07
• 2. 用血栓烷-A2受体拮抗剂治疗肌营养不良的组合物和方法 [P] . 中国专利： CN109152767A . 2019-01-04
• 3. Pharmaceutical composition containing a prostaglandin analog which is a thromboxane a2 receptor antagonist [P] . IL97513A . 1996-05-14

  机译： 包含前列腺素类似物的药物组合物，所述前列腺素类似物是血栓素a 2受体拮抗剂

• 4. A PHARMACEUTICAL COMPOSITION CONTAINING A THROMBOXANE A2 RECEPTOR ANTAGONIST PROSTAGLANDIN ANALOG [P] . IL97513D0 . 1992-06-21

  机译： 包含血栓烷A2受体拮抗剂前列腺素的药物组合物

• 5. PHARMACEUTICAL COMPOSITIONS CONTAINING A 7-OXA-BICYCLOHEPTANE PROSTAGLANDIN ANALOGUE AS A THROMBANE A2 RECEPTOR ANTAGONIST [P] . NZ232110A . 1997-03-24

  机译： 包含7-氧杂双环庚烷前列腺素类似物的药物组合物，作为TH2受体拮抗剂

• 1. Growth Hormone Releasing Hormone Receptors Antagonists and Cancers: Do GHRH-R Antagonists Play a Role in the Management of Prostate Cancer? [J] . Joseph Bertin Alexis Zoa Bindzi, Yingjie Yang, Xiaoqi Yan, 泌尿学期刊（英文） . 2020,第006期
• 2. Kappa opioid receptor antagonist and N-methyl-D- aspartate receptor antagonist affect dynorphin- induced spinal cord electrophysiologic impairment [J] . Yu Chen, Liangbi Xiang, Jun Liu, 中国神经再生研究（英文版） . 2012,第007期
• 3. EFFECT OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND ENDOTHELIN RECEPTOR ANTAGONIST ON NITROGLYCERIN TOLERANCE IN RATS [J] . 中国医学科学杂志（英文版） . 2001,第002期
• 4. EFFECT OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND ENDOTHELIN RECEPTOR ANTAGONIST ON NITROGLYCERIN TOLERANCE IN RATS [J] . 张建梅, 陈永红, 王晓红, 中国医学科学杂志：英文版 . 2001,第002期
• 5. Tandem Mass Spectrometry and H/D Exchange of Protonated 1,1'-Bis(Diphenylphosphino)-Ferrocene Oxidation Impurity Generated in the Synthesis of a Pharmaceutical Calcium Receptor Antagonist [C] . Lianming Wu, Heriberto Hernandez-Soto, Stacy ONeill-Slawecki, ASMS Conference on Mass Spectrometry and Allied Topics . 2007
• 6. An antagonist of the prostaglandin F2alpha receptor (FP)-Galphaq-dependent response, biases FP into mitogen-activated protein kinase (MAPK) signalling through epidermal growth factor receptor (EGFR) transactivation . [D] . Wisehart, Veronica. 2011
• 7. Kinetic studies on stereospecific recognition by the thromboxane A2/prostaglandin H2 receptor of the antagonist S-145. [O] . J. Kishino, K. Hanasaki, T. Nagasaki, 1991
• 8. Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT). [O] . 1994

• 1. Expression and localization of prostaglandin receptors and stromal factors in human cervix—Variations in pregnant and non-pregnant states [J] . Chellakkan S. Blesson ,Nathalie Roos ,Olof Stephansson . 分子和综合生理学期刊（英文） . 2013,第4期
• 2. 三七总皂苷联合奥扎格雷钠对血栓素A2合成酶的抑制作用及相互影响 [C] . WU Hui-chao ,武慧超 ,BAI Jie . 第六届全国中医药博士生学术论坛 . 2015
• 3. 血栓素A2受体拮抗剂雷马曲班对足细胞凋亡及nephrin表达的影响 [A] . 邹锋 . 2016